Evidence map›Paper›PMID 18350135›Full record

ArticlePloS one2008

Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults.

M Estee Torok, Tran Thi Hong Chau, Pham Phuong Mai, Nguyen Duy Phong, Nguyen Thi Dung, Ly Van Chuong, Sue J Lee, M Caws, Menno D de Jong, Tran Tinh Hien and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2011
    Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Human Fungal Infections in Kuwait-Burden and Diagnostic Gaps.Journal of fungi (Basel, Switzerland) · 2020
    Article
  10. Article
  11. The pathogenesis of tuberculous meningitis.Journal of leukocyte biology · 2019
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Prognostic Models for 9-Month Mortality in Tuberculous Meningitis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  17. Review
  18. Standardized Methods for Enhanced Quality and Comparability of Tuberculous Meningitis Studies.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Review
  19. Article
  20. Six months therapy for tuberculous meningitis.The Cochrane database of systematic reviews · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

M Estee TorokOxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam. etorok@oucru.org
Tran Thi Hong Chau
Pham Phuong Mai
Nguyen Duy Phong
Nguyen Thi Dung
Ly Van Chuong
Sue J Lee
M Caws
Menno D de Jong
Tran Tinh Hien
Jeremy J Farrar
Hospital for Tropical Diseases · VNChurchill Hospital · GBMahidol Oxford Tropical Medicine Research Unit · THOxford University Clinical Research Unit · VNUniversity of Oxford · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

methodsThe aim of this prospective, observational cohort study was to determine the clinical and microbiological features, outcome, and baseline variables predictive of death, in Vietnamese adults with HIV-associated tuberculous meningitis (TBM). 58 patients were admitted to the Hospital for Tropical Diseases in Ho Chi Minh City and underwent routine clinical and laboratory assessments. Treatment was with standard antituberculous therapy and adjunctive dexamethasone; antiretroviral therapy was not routinely available. Patients were followed up until the end of TB treatment or death.

resultsThe median symptom duration was 11 days (range 2-90 days), 21.8% had a past history of TB, and 41.4% had severe (grade 3) TBM. The median CD4 count was 32 cells/mm(3). CSF findings were as follows: median leucocyte count 438 x 10(9)cells/l (63% neutrophils), 69% smear positive and 87.9% culture positive. TB drug resistance rates were high (13% mono-resistance 32.6% poly-resistance 8.7% multidrug resistance). 17% patients developed further AIDS-defining illnesses. 67.2% died (median time to death 20 days). Three baseline variables were predictive of death by multivariate analysis: increased TBM grade [adjusted hazard ratio (AHR) 1.73, 95% CI 1.08-2.76, p = 0.02], lower serum sodium (AHR 0.93, 95% CI 0.89 to 0.98, p = 0.002) and decreased CSF lymphocyte percentage (AHR 0.98, 95% CI 0.97 to 0.99, p = 0.003).

conclusionsHIV-associated TBM is devastating disease with a dismal prognosis. CSF findings included CSF neutrophil predominance, high rates of smear and culture positivity, and high rates of antituberculous drug resistance. Three baseline variables were independently associated with death: increased TBM grade; low serum sodium and decreased CSF lymphocyte percentage.

Indexed as

AdultAIDS-Related Opportunistic InfectionsAntitubercular AgentsCohort StudiesDrug Therapy, CombinationFemaleHumansMaleMiddle AgedPrevalenceTuberculosis, MeningealVietnamAntitubercular Agents

Identifiers

PMID18350135
PMCPMC2262136
OpenAlexW1994497197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.